Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria
about
Preclinical Assessment of Viral Vectored and Protein Vaccines Targeting the Duffy-Binding Protein Region II of Plasmodium VivaxMerozoite surface proteins in red blood cell invasion, immunity and vaccines against malariaImmune Escape Strategies of Malaria ParasitesInsights into the Immunological Properties of Intrinsically Disordered Malaria Proteins Using Proteome Scale Predictions.Immunity as a predictor of anti-malarial treatment failure: a systematic reviewA Plasmodium Promiscuous T Cell Epitope Delivered within the Ad5 Hexon Protein Enhances the Protective Efficacy of a Protein Based Malaria VaccineBreadth of humoral response and antigenic targets of sporozoite-inhibitory antibodies associated with sterile protection induced by controlled human malaria infectionStandardization of the antibody-dependent respiratory burst assay with human neutrophils and Plasmodium falciparum malariaIFNAR1-Signalling Obstructs ICOS-mediated Humoral Immunity during Non-lethal Blood-Stage Plasmodium Infection.Vaccine candidate discovery for the next generation of malaria vaccines.Contrasting Patterns of Serologic and Functional Antibody Dynamics to Plasmodium falciparum Antigens in a Kenyan Birth CohortStrain-transcending immune response generated by chimeras of the malaria vaccine candidate merozoite surface protein 2.Targets and Mechanisms Associated with Protection from Severe Plasmodium falciparum Malaria in Kenyan Children.Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01Progress and prospects for blood-stage malaria vaccinesAcquisition of Functional Antibodies That Block the Binding of Erythrocyte-Binding Antigen 175 and Protection Against Plasmodium falciparum Malaria in ChildrenThe association between naturally acquired IgG subclass specific antibodies to the PfRH5 invasion complex and protection from Plasmodium falciparum malaria.A single point in protein trafficking by Plasmodium falciparum determines the expression of major antigens on the surface of infected erythrocytes targeted by human antibodies.A chimeric protein-based malaria vaccine candidate induces robust T cell responses against Plasmodium vivax MSP119.Association between malaria immunity and pregnancy outcomes among Malawian pregnant women receiving nutrient supplementation.Somatically Hypermutated Plasmodium-Specific IgM(+) Memory B Cells Are Rapid, Plastic, Early Responders upon Malaria RechallengeDevelopment of Plasmodium falciparum specific naïve, atypical, memory and plasma B cells during infancy and in adults in an endemic area.Single-cell RNA-seq and computational analysis using temporal mixture modelling resolves Th1/Tfh fate bifurcation in malaria.Dichotomous miR expression and immune responses following primary blood-stage malaria.The immunological balance between host and parasite in malaria.Blood-stage malaria vaccines: post-genome strategies for the identification of novel vaccine candidates.Immunity to malaria in an era of declining malaria transmission.Examining cellular immune responses to inform development of a blood-stage malaria vaccine.Immunological processes underlying the slow acquisition of humoral immunity to malaria.Complement and Antibody-mediated Enhancement of Red Blood Cell Invasion and Growth of Malaria Parasites.Malaria vaccines and human immune responses.Host immunity to Plasmodium falciparum and the assessment of emerging artemisinin resistance in a multinational cohort.The Impact of Established Immunoregulatory Networks on Vaccine Efficacy and the Development of Immunity to Malaria.Differing rates of antibody acquisition to merozoite antigens in malaria: implications for immunity and surveillance.Regulatory T cells impede acute and long-term immunity to blood-stage malaria through CTLA-4.Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.Patterns of protective associations differ for antibodies to P.falciparum-infected erythrocytes and merozoites in immunity against malaria in children.Acquisition, maintenance and adaptation of invasion inhibitory antibodies against Plasmodium falciparum invasion ligands involved in immune evasion.IL-6 promotes CD4+ T-cell and B-cell activation during Plasmodium infection.Lipid interactions modulate the structural and antigenic properties of the C-terminal domain of the malaria antigen merozoite surface protein 2.
P2860
Q24273364-91A9E172-84CE-4770-AD23-2AB706D86F49Q26772878-5EDA314F-C631-4641-AFDC-12460DD230E8Q28072043-0ED9ECEA-F456-4145-B976-2CF7A5EB14BFQ30380793-AC1CFABF-D02A-45FF-95A6-2C9F1AD1CCBBQ33582154-5DC7D4F6-4654-4B09-BE2F-C4F849734851Q36003208-B442CFAA-516F-48D2-AC76-C4C9FD87ACE7Q36004060-C96C9ECF-B9A8-4C41-8774-1170EE77E3D4Q36064542-4E815371-5AB2-4C49-84D8-AAE6FA4D008FQ36182425-E13FDB18-15F2-4D8A-A9E0-1D5FE889DAA4Q36413834-69ED168E-62A4-4883-8A94-AE4E8BF45A2BQ36555103-210D8ED6-F20B-4C2B-ADEA-B8A2114B2AFAQ36569534-598A2F77-2852-4939-A8CF-415173313204Q36728063-3036FC61-CCF2-4778-A0D9-6A7D67886DF6Q36871970-E23B44CD-EF2F-4A0C-8DFA-309DB09D8150Q37025030-8BAFE8AE-6F67-461D-90BA-C728A13A859EQ37220749-120555F3-F2B1-4917-B4DC-C6D58B4BA44FQ37239883-CA14D880-F9E3-460F-87AF-850FC23094D1Q37298050-9C9DF3E6-B713-4951-B60D-830C607CD74FQ37314756-DC5065AC-A3AA-4313-98BF-A3993CCE7585Q37406034-1DB007FF-BC5F-4911-B217-E44AA5B40C22Q37427351-37C235D8-1F68-4B7F-99B3-BBD317F70D95Q37597307-4BF68736-CFB8-4381-B628-150575DF455AQ37720375-02D062B0-2997-4931-97D2-D222467FA7B5Q38645943-88D7C95D-6CA7-4F99-B800-DB54A111CD2DQ38666558-58C9FC5F-8E81-4934-8A46-10EBBB1D2DE2Q38672088-37013C32-1FC5-4DCA-807E-1562A62D37CAQ38689264-B9FF3478-6039-40F7-901F-FD032E9FC6E8Q38689861-5A7E01F3-0758-4E1F-B565-778F09EBEBC2Q38690037-BD780B9C-DDF5-4A38-9267-649677826B16Q38849729-8E824EC0-BBE3-45AF-943E-0A7A74DD8866Q38854831-412A4F29-AEA7-45BA-B41E-DFCF2558024BQ38882700-72DE6C73-EB3B-4BBF-9CF0-BFD329D3E705Q39027956-C091EB91-08FB-48F2-9052-4E1593B5687CQ39230991-2D604C45-DAB9-4A3D-A1A3-D7A1B51D6DEDQ40047869-76FB8EFC-B13B-486F-876A-17D890AD27F9Q40055186-C66A83B3-68B2-4E95-8CA4-CDED95C92D8EQ40073901-02230C12-DAA8-46B1-8B22-30D232340531Q40102134-AAB1E4AE-CF44-4042-874F-63E83BD1BC0EQ40117722-20F00CC2-578A-4439-B7D0-7739E5D9C1F0Q40171072-96467B15-5F27-418B-86F4-5CF1FEEE2F99
P2860
Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Human antibodies fix complemen ...... ith protection against malaria
@ast
Human antibodies fix complemen ...... ith protection against malaria
@en
type
label
Human antibodies fix complemen ...... ith protection against malaria
@ast
Human antibodies fix complemen ...... ith protection against malaria
@en
prefLabel
Human antibodies fix complemen ...... ith protection against malaria
@ast
Human antibodies fix complemen ...... ith protection against malaria
@en
P2093
P2860
P50
P921
P1433
P1476
Human antibodies fix complemen ...... ith protection against malaria
@en
P2093
Christine Langer
Gaoqian Feng
Harvey Aspeling-Jones
Ivo Muller
Janine Stubbs
Kevin K A Tetteh
Linda Reiling
Yik Sheng Cheng
P2860
P304
P356
10.1016/J.IMMUNI.2015.02.012
P407
P50
P577
2015-03-01T00:00:00Z